We are live on ! Find out more
ICCC icon

ImmuCell
ICCC

15 hedge funds and large institutions have $4.34M invested in ImmuCell in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 2

2.95% less ownership

Funds ownership: 16.17% → 13.22% (-2.9%)

6% less funds holding

Funds holding: 16 → 15 (-1)

25% less capital invested

Capital invested by funds: $5.75M → $4.34M (-$1.41M)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
15
Holders Change
-1
Holders Change %
-6.25%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
8
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$120K
2
EIM
Essex Investment Management
Massachusetts
+$106K
3
Morgan Stanley
Morgan Stanley
New York
+$79.2K
4
Deutsche Bank
Deutsche Bank
Germany
+$77.9K
5
SRC
Shufro Rose & Co
New York
+$36.7K

Top Sellers

Rank Fund Capital Flow
1
HP
HealthInvest Partners
Sweden
-$1.33M
2
UBS Group
UBS Group
Switzerland
-$10.4K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$10.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
HA
1
Heartland Advisors
Wisconsin
$1.46M – – –
PCM
2
Perritt Capital Management
Illinois
$870K +$18.7K +2,859 +2%
Renaissance Technologies
3
Renaissance Technologies
New York
$638K +$120K +18,300 +23%
SRC
4
Shufro Rose & Co
New York
$324K +$36.7K +5,600 +13%
Vanguard Group
5
Vanguard Group
Pennsylvania
$210K -$10.1K -1,542 -5%
EIM
6
Essex Investment Management
Massachusetts
$174K +$106K +16,249 +155%
Wells Fargo
7
Wells Fargo
California
$161K +$11.1K +1,701 +7%
EFS
8
Essex Financial Services
Connecticut
$155K – – –
Morgan Stanley
9
Morgan Stanley
New York
$126K +$79.2K +12,100 +165%
MA
10
Minerva Advisors
Pennsylvania
$93K – – –
Deutsche Bank
11
Deutsche Bank
Germany
$77K +$77.9K +11,900 New
UBS Group
12
UBS Group
Switzerland
$26K -$10.4K -1,594 -28%
Bank of America
13
Bank of America
North Carolina
$13K +$98 +15 +0.7%
BlackRock
14
BlackRock
New York
$5K – – –
Royal Bank of Canada
15
Royal Bank of Canada
Ontario, Canada
$3K +$7 +1 +0.2%
HP
16
HealthInvest Partners
Sweden
– -$1.33M -182,133 Closed

ICCC Hedge Fund Activity: Q3 2017 in Review

15 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q3 2017, worth a combined $4.34M — down 25% from $5.75M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of ICCC and 1 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 8 added.

The largest buyer was Renaissance Technologies, adding an estimated $120K. The largest seller was HealthInvest Partners, exiting entirely with an estimated $1.33M sold.

  • 15 institutional investors held ImmuCell (ICCC) as of Q3 2017, down from 16 in Q2 2017.
  • Funds reported $4.34M of ImmuCell stock for Q3 2017, down 25% quarter-over-quarter.
  • 1 fund opened new ImmuCell positions in Q3 2017 and 2 closed out, a net change of -1 holder.
  • The largest ImmuCell buyer in Q3 2017 was Renaissance Technologies, an estimated $120K added.
  • The largest ImmuCell seller in Q3 2017 was HealthInvest Partners, an estimated $1.33M sold.

Based on aggregated 13F filings for Q3 2017.